Safety of a Cardiac Resynchronization Therapy Device Implantation in a Patient with Unstable Heart Failure Who Require Impella-Device Assistance.

Acute pulmonary edema Biventricular pacing LV dyssynchrony LV unloading Percutaneous mechanical circulatory support

Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
31 May 2022
Historique:
pubmed: 16 5 2022
medline: 7 6 2022
entrez: 15 5 2022
Statut: ppublish

Résumé

Implantation of a cardiac resynchronization therapy (CRT) device is usually scheduled in the compensated phase of heart failure; however, procedural safety may be sometimes disturbed in the decompensated phase. We report a case of a successful semi-urgent implantation of a CRT device temporary assisted with Impella in a patient with the decompensated phase of severe heart failure dependent on inotropic agents and who cannot maintain the supine position. Impella assistance with left ventricular (LV) unloading and maintenance of end-organ perfusion contributed to early recovery from acute heart failure. Furthermore, an acute effect of mechanical resynchronization by biventricular pacing plays an important role in weaning from the mechanical support or inotropic dependence. These mutual effects of mechanical support and CRT might contribute to a decrease in LV end-diastolic pressure and to a remarkable early recovery from a severely decompensated condition.

Identifiants

pubmed: 35569963
doi: 10.1536/ihj.21-616
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-626

Auteurs

Kyoko Unno (K)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.
Department of Cardiology, Seirei Mikatahara General Hospital.

Makoto Sano (M)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Yutaro Kaneko (Y)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Keitaro Akita (K)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Tomoaki Sakakibara (T)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Ryota Sato (R)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Taro Narumi (T)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Keisuke Iguchi (K)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Satoshi Mogi (S)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Kenichiro Suwa (K)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Yoshihisa Naruse (Y)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Hayato Ohtani (H)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Masao Saotome (M)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Tsuyoshi Urushida (T)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Yuichiro Maekawa (Y)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH